Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) recommendations for pathological examination and reporting

被引：94
|
作者：
Wardelmann, E. [1 ]
Haas, R. L. [2 ]
Bovee, J. V. M. G. [3 ]
Terrier, Ph [4 ]
Lazar, A. [5 ]
Messiou, C. [6 ]
LePechoux, C. [7 ]
Hartmann, W. [1 ]
Collin, F. [8 ]
Fisher, C. [9 ]
Mechtersheimer, G. [10 ]
DeiTos, A. P. [11 ]
Stacchiotti, S. [12 ]
Jones, R. L. [13 ]
Gronchi, A. [14 ]
Bonvalot, S. [15 ]
机构：
[1] Univ Hosp, Gerhard Domagk Inst Pathol, Munster, Germany
[2] Netherlands Canc Inst, Dept Radiotherapy, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands
[3] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands
[4] Gustave Roussy, Dept Med Biol & Pathol, Villejuif, France
[5] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[6] Royal Marsden Hosp, Dept Radiol, London SW3 6JJ, England
[7] Inst Gustave Roussy, Dept Radiotherapy, Paris, France
[8] Ctr Georges Francois Leclerc, Dept Pathol, Dijon, France
[9] Royal Marsden Hosp, Sarcoma Unit, London SW3 6JJ, England
[10] Heidelberg Univ, Inst Pathol, Bergheimer Str 58, D-69115 Heidelberg, Germany
[11] Gen Hosp Treviso, Dept Oncol & Anat Pathol, Treviso, Italy
[12] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy
[13] Royal Marsden Hosp, Dept Med Oncol, London SW3 6JJ, England
[14] Fdn IRCCS Ist Nazl Tumori, Dept Surg, Milan, Italy
[15] Inst Curie, Dept Surg, Paris, France
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 53卷
关键词：
Soft tissue sarcoma; Radiotherapy; Chemotherapy; Response evaluation; Pathology; Guideline; PREOPERATIVE HYPOFRACTIONATED RADIOTHERAPY; HIGH-RISK EXTREMITY; PHASE-I TRIAL; HIGH-GRADE; HISTOLOGIC RESPONSE; HISTOPATHOLOGIC RESPONSE; PROGNOSTIC-SIGNIFICANCE; RADIATION-THERAPY; EWINGS-SARCOMA; PLUS SORAFENIB;
D O I：
10.1016/j.ejca.2015.09.021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
At present, there is not a commonly used and generally accepted standardized approach for the pathologic evaluation of pretreated soft tissue sarcomas. Also, it is still unclear whether the cut-off for prognostic relevance is similar in the many different histological subtypes of STS. This manuscript, produced by a European Organization for Research and Treatment of Cancer - Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) endorsed task force, aims to propose standardization of the pathological examination process and the reporting of STS resection specimens after neoadjuvant radio-and/or chemotherapy. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码：84 / 95
页数：12
相关论文
共 50 条
  • [1] Histopathologic Tumor Response Following Neoadjuvant Hyperthermic Isolated Limb Perfusion in Extremity Soft Tissue Sarcomas, the Prognostic Value of the European Organization for Research and Treatment of Cancer: Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) Response Score
    Stevenson, M. G.
    Hoekstra, H.
    Song, W.
    Been, L. B.
    Suurmeijer, A. J.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S195 - S195
  • [2] Evaluation of response after pre-operative radiotherapy in soft tissue sarcomas; the European Organisation for Research and Treatment of Cancer - Soft Tissue and Bone Sarcoma Group (EORTC - STBSG) and Imaging Group recommendations for radiological examination and reporting with an emphasis on magnetic resonance imaging
    Messiou, C.
    Bonvalot, S.
    Gronchi, A.
    Vanel, D.
    Meyer, M.
    Robinson, P.
    Morosi, C.
    Bloem, J. L.
    Terrier, P. H.
    Lazar, A.
    Le Pechoux, C.
    Wardelman, E.
    Winfield, J. M.
    Boulet, B.
    Bovee, J.
    Haas, R. L.
    EUROPEAN JOURNAL OF CANCER, 2016, 56 : 37 - 44
  • [3] Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG)
    Lindner, Lars H.
    Litiere, Saskia
    Sleijfer, Stefan
    Benson, Charlotte
    Italiano, Antoine
    Kasper, Bernd
    Messiou, Christina
    Gelderblom, Hans
    Wardelmann, Eva
    Le Cesne, Axel
    Blay, Jean-Yves
    Marreaud, Sandrine
    Hindi, Nadia
    Desar, Ingrid M. E.
    Gronchi, Alessandro
    van der Graaf, Winette T.
    INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (12) : 2610 - 2620
  • [4] Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas An exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG)
    Sleijfer, Stefan
    Ouali, Monia
    van Glabbeke, Martine
    Krarup-Hansen, Anders
    Rodenhuis, Sjoerd
    Le Cesne, Axel
    Hogendoorn, Pancras C. W.
    Verweij, Jaap
    Blay, Jean-Yves
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (01) : 72 - 83
  • [5] Surgical treatment of lung metastases - The European organization for research and treatment of cancer-soft tissue and bone sarcoma group study of 255 patients
    vanGeel, AN
    Pastorino, U
    Jauch, KW
    Judson, IR
    vanCoevorden, F
    Buesa, JM
    Nielsen, OS
    Boudinet, A
    Tursz, T
    Schmitz, PIM
    CANCER, 1996, 77 (04) : 675 - 682
  • [6] Prognostic factors in soft tissue sarcoma patients with lung metastases only receiving first-line chemotherapy. An exploratory, retrospective analysis on fifteen trials of the European Organization for Research and Treatment of Cancer - Soft Tissue and Bone Sarcoma Group (EORTC-STBSG)
    Lindner, L.
    Litiere, S.
    Sleijfer, S.
    Judson, I.
    Italiano, A.
    Kasper, B.
    Gelderblom, H.
    Marreaud, S.
    Wardelmann, E.
    Gronchi, A.
    Van der Graaf, W.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S701 - S701
  • [7] TREATMENT OF ADVANCED SOFT-TISSUE SARCOMAS WITH LOW-DOSE METHOTREXATE - A PHASE-II TRIAL BY THE EUROPEAN ORGANIZATION FOR RESEARCH ON TREATMENT OF CANCER (EORTC) SOFT-TISSUE AND BONE SARCOMA GROUP
    BUESA, JM
    MOURIDSEN, HT
    SANTORO, A
    SOMERS, R
    BRAMWELL, V
    VANOOSTEROM, AT
    WAGENER, T
    VENDRIK, C
    THOMAS, D
    CANCER TREATMENT REPORTS, 1984, 68 (04): : 683 - 684
  • [8] Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis
    Kollar, A.
    Jones, R. L.
    Stacchiotti, S.
    Gelderblom, H.
    Guida, M.
    Grignani, G.
    Steeghs, N.
    Safwat, A.
    Katz, D.
    Duffaud, F.
    Sleijfer, S.
    van der Graaf, W. T.
    Touati, N.
    Litiere, S.
    Marreaud, S.
    Gronchi, A.
    Kasper, B.
    ACTA ONCOLOGICA, 2017, 56 (01) : 88 - 92
  • [9] Histopathological tumor response following neoadjuvant hyperthermic isolated limb perfusion in extremity soft tissue sarcomas: Evaluation of the EORTC-STBSG response score
    Stevenson, Marc G.
    Hoekstra, Harald J.
    Song, Wangzhao
    Suurmeijer, Albert J. H.
    Been, Lukas B.
    EJSO, 2018, 44 (09): : 1406 - 1411
  • [10] Phase II study of ET-743 in advanced soft tissue sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial
    Le Cesne, A
    Blay, JY
    Judson, I
    Van Oosterom, A
    Verweij, J
    Radford, J
    Lorigan, P
    Rodenhuis, S
    Ray-Coquard, I
    Bonvalot, S
    Collin, F
    Jimeno, J
    Di Paola, E
    Van Glabbeke, M
    Nielsen, OS
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (03) : 576 - 584
12345